Researchers have found that a natural molecule can effectively block the binding of a subset of human antibodies to SARS-CoV-2. The discovery may help explain why some COVID-19 patients can become severely ill despite...
For the first time, a team of researchers has captured X-ray images of a critical enzyme of the COVID-19 virus performing its function. This discovery could improve design of new treatments against the disease. The...
SARS-CoV-2, which is the virus that causes COVID-19, is not the only zoonotic coronavirus. In fact, it is the third to have emerged since the turn of the century. It was preceded by severe respiratory syndrome (SARS) in...
It is the world’s most pressing scientific puzzle. Pieces scattered around the world are being collected in search of a suspect in the largest health crisis to ever hit the globe in the past century. With the...
The major clinical manifestations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection include fever, dry cough, fatigue, and other respiratory symptoms. Recent studies show that over 60% of...
The emergence of several, more infectious strains of the novel coronavirus SARS-CoV-2 has worried governments and scientists, who are investigating how and why the virus became more transmissible. Like all viruses, SARS...
In a multi-group collaborative involving the National Emerging Infectious Disease Laboratories (NEIDL), the Center for Regenerative Medicine (CReM), and the Center for Network Systems Biology (CNSB), scientists have...
A JAMA Internal Medicine research letter finds that 18% of recovered COVID-19 patients test positive for SARS-CoV-2, the virus that causes COVID-19, but only 3% (1 of 32) carry replicating virus in their respiratory...
The ongoing global pandemic has created an urgent need for rapid tests that can diagnose the presence of the SARS-CoV-2 virus, the pathogen that causes COVID-19, and distinguish it from other respiratory viruses. Now...
The Oxford vaccine trial at the center of safety concerns highlights the idea that people’s immune systems respond to vaccines differently. We don’t yet know whether reports of immune complications in one or two trial...